来伐替尼联合PD-1/PD-L1抑制剂治疗肝细胞癌的疗效和安全性：荟萃分析和系统综述

{"title":"来伐替尼联合PD-1/PD-L1抑制剂治疗肝细胞癌的疗效和安全性：荟萃分析和系统综述","authors":"Baoyan Zhang, Linfeng Su, Yonghua Lin","doi":"10.3892/ol.2024.14445","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":508560,"journal":{"name":"Oncology Letters","volume":"102 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and safety of lenvatinib combined with PD‑1/PD‑L1 inhibitors in the treatment of hepatocellular carcinoma: A meta‑analysis and systematic review\",\"authors\":\"Baoyan Zhang, Linfeng Su, Yonghua Lin\",\"doi\":\"10.3892/ol.2024.14445\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":508560,\"journal\":{\"name\":\"Oncology Letters\",\"volume\":\"102 8\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology Letters\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3892/ol.2024.14445\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Letters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3892/ol.2024.14445","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}